Presarcopenia and Its Impact on Disability in Female Patients With Rheumatoid Arthritis

Overview

Journal Arch Rheumatol

Specialty Rheumatology

Date 2018 Oct 31

PMID 30375535

Citations 8

Authors

Meltem Alkan Melikoglu

Affiliations

Soon will be listed here.

Abstract

Objectives: This cross-sectional pilot study aims to investigate presarcopenia in female patients with rheumatoid arthritis (RA) and to evaluate its relationship to the disability assessment.

Patients And Methods: Forty female patients with RA (mean age 48.29±8.34; range 31 to 66 years) and 40 healthy controls (mean age 46.21±6.90; range 31 to 58 years) matched for age, sex, and body mass index were included. Pain, morning stiffness duration, disease activity score, erythrocyte sedimentation rate, C-reactive protein, and Health Assessment Questionnaire (HAQ) were evaluated. Body compositions were assessed with whole body dual energy X-ray absorptiometry. The appendicular skeletal muscle mass and skeletal muscle mass index (SMI) of RA patients were compared to the controls and possible correlations between SMI, disease characteristics, and HAQ score were investigated.

Results: The body mass index values and percentages of obese, overweight, and healthy weight subjects were similar in the patient and control groups. However, appendicular skeletal muscle mass and SMI calculations were significantly lower, and the percentage of presarcopenia was significantly higher in patients with RA (20%) than controls (7%) (p<0.05). Although there was no significant correlation between SMI and other parameters, a significant negative correlation was determined between SMI and HAQ score in patients with RA (p<0.05).

Conclusion: We demonstrated lower SMI values and higher presarcopenia ratios in patients with RA than healthy controls. Independent from other disease characteristics, the inverse correlation between SMI and HAQ scores may contribute to understanding of the impact of the process on patient disability.

Citing Articles

Assessment of sarcopenia in young patients with inflammatory arthritis: a cross-sectional study.

Kulyk M, Dzhus M Sci Rep. 2025; 15(1):8236.

PMID: 40064969 PMC: 11893876. DOI: 10.1038/s41598-025-88939-9.

Sarcopenia in Rheumatoid arthritis. A narrative review.

Moschou D, Krikelis M, Georgakopoulos C, Mole E, Chronopoulos E, Tournis S J Frailty Sarcopenia Falls. 2023; 8(1):44-52.

PMID: 36873824 PMC: 9975974. DOI: 10.22540/JFSF-08-044.

Risk Factors of Muscle Wasting in Women with Rheumatoid Arthritis: Relevance of the Persistent Failure of Conventional Combination Therapy.

Gomez-Ramirez E, Ramirez-Villafana M, Gamez-Nava J, Cons-Molina F, Rodriguez Jimenez N, Saldana-Cruz A Healthcare (Basel). 2022; 10(10).

PMID: 36292451 PMC: 9602608. DOI: 10.3390/healthcare10102004.

Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition.

Dietzel R, Wiegmann S, Borucki D, Detzer C, Zeiner K, Schaumburg D RMD Open. 2022; 8(2).

PMID: 36180102 PMC: 9528715. DOI: 10.1136/rmdopen-2022-002600.

Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis.

Li Z, Tong X, Ma Y, Bao T, Yue J J Cachexia Sarcopenia Muscle. 2022; 13(1):128-144.

PMID: 34997702 PMC: 8818614. DOI: 10.1002/jcsm.12908.

References

Prevoo M, van t Hof M, Kuper H, van Leeuwen M, van de Putte L, van Riel P . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(1):44-8. DOI: 10.1002/art.1780380107. View

Han D, Chang K, Li C, Lin Y, Kao T, Tsai K . Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia. Sci Rep. 2016; 6:19457. PMC: 4726295. DOI: 10.1038/srep19457. View

Muscaritoli M, Anker S, Argiles J, Aversa Z, Bauer J, Biolo G . Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29(2):154-9. DOI: 10.1016/j.clnu.2009.12.004. View

Book C, Karlsson M, Akesson K, Jacobsson L . Early rheumatoid arthritis and body composition. Rheumatology (Oxford). 2009; 48(9):1128-32. DOI: 10.1093/rheumatology/kep165. View

Kucukdeveci A, Sahin H, Ataman S, Griffiths B, Tennant A . Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum. 2004; 51(1):14-9. DOI: 10.1002/art.20091. View

Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View

Bianchi G, Rossi V, Muscari A, Magalotti D, Zoli M . Physical activity is negatively associated with the metabolic syndrome in the elderly. QJM. 2008; 101(9):713-21. DOI: 10.1093/qjmed/hcn084. View

Wolfe F, Kleinheksel S, Cathey M, Hawley D, Spitz P, Fries J . The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol. 1988; 15(10):1480-8. View

Tanko L, Movsesyan L, Mouritzen U, Christiansen C, Svendsen O . Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metabolism. 2002; 51(1):69-74. DOI: 10.1053/meta.2002.28960. View

10.

Teixeira V, Filippin L, Xavier R . Mechanisms of muscle wasting in sarcopenia. Rev Bras Reumatol. 2012; 52(2):252-9. View

11.

Cawthon P, Marshall L, Michael Y, Dam T, Ensrud K, Barrett-Connor E . Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007; 55(8):1216-23. DOI: 10.1111/j.1532-5415.2007.01259.x. View

12.

Baumgartner R, Koehler K, Gallagher D, Romero L, Heymsfield S, Ross R . Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147(8):755-63. DOI: 10.1093/oxfordjournals.aje.a009520. View

13.

Summers G, Deighton C, Rennie M, Booth A . Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford). 2008; 47(8):1124-31. DOI: 10.1093/rheumatology/ken146. View

14.

Pahor M, Manini T, Cesari M . Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging. 2009; 13(8):724-8. PMC: 4312657. DOI: 10.1007/s12603-009-0204-9. View

15.

Gallagher D, Visser M, De Meersman R, Sepulveda D, Baumgartner R, Pierson R . Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol (1985). 1997; 83(1):229-39. DOI: 10.1152/jappl.1997.83.1.229. View

16.

Guralnik J, Fried L, Salive M . Disability as a public health outcome in the aging population. Annu Rev Public Health. 1996; 17:25-46. DOI: 10.1146/annurev.pu.17.050196.000325. View

17.

Phillips S . Nutritional supplements in support of resistance exercise to counter age-related sarcopenia. Adv Nutr. 2015; 6(4):452-60. PMC: 4496741. DOI: 10.3945/an.115.008367. View

18.

Dao H, Do Q, Sakamoto J . Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology (Oxford). 2011; 50(7):1250-8. DOI: 10.1093/rheumatology/ker004. View

19.

Giles J, Ling S, Ferrucci L, Bartlett S, Andersen R, Towns M . Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008; 59(6):807-15. PMC: 2670994. DOI: 10.1002/art.23719. View

20.

Rolland Y, Czerwinski S, Abellan van Kan G, Morley J, Cesari M, Onder G . Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008; 12(7):433-50. PMC: 3988678. DOI: 10.1007/BF02982704. View